Search

everythinglearnresearchcommunity

for

Search:↓

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

High BMI worsens hair growth in women with PCOS.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.